1. Home
  2. LXEO vs VERI Comparison

LXEO vs VERI Comparison

Compare LXEO & VERI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXEO
  • VERI
  • Stock Information
  • Founded
  • LXEO 2017
  • VERI 2014
  • Country
  • LXEO United States
  • VERI United States
  • Employees
  • LXEO N/A
  • VERI N/A
  • Industry
  • LXEO
  • VERI EDP Services
  • Sector
  • LXEO
  • VERI Technology
  • Exchange
  • LXEO Nasdaq
  • VERI Nasdaq
  • Market Cap
  • LXEO 140.6M
  • VERI 124.0M
  • IPO Year
  • LXEO 2023
  • VERI 2017
  • Fundamental
  • Price
  • LXEO $4.10
  • VERI $2.55
  • Analyst Decision
  • LXEO Strong Buy
  • VERI Strong Buy
  • Analyst Count
  • LXEO 5
  • VERI 2
  • Target Price
  • LXEO $22.80
  • VERI $5.25
  • AVG Volume (30 Days)
  • LXEO 919.4K
  • VERI 400.4K
  • Earning Date
  • LXEO 03-24-2025
  • VERI 03-13-2025
  • Dividend Yield
  • LXEO N/A
  • VERI N/A
  • EPS Growth
  • LXEO N/A
  • VERI N/A
  • EPS
  • LXEO N/A
  • VERI N/A
  • Revenue
  • LXEO N/A
  • VERI $92,637,000.00
  • Revenue This Year
  • LXEO N/A
  • VERI $21.87
  • Revenue Next Year
  • LXEO N/A
  • VERI $22.69
  • P/E Ratio
  • LXEO N/A
  • VERI N/A
  • Revenue Growth
  • LXEO N/A
  • VERI N/A
  • 52 Week Low
  • LXEO $2.32
  • VERI $2.03
  • 52 Week High
  • LXEO $19.50
  • VERI $7.76
  • Technical
  • Relative Strength Index (RSI)
  • LXEO 57.61
  • VERI 44.86
  • Support Level
  • LXEO $3.75
  • VERI $2.60
  • Resistance Level
  • LXEO $4.59
  • VERI $2.84
  • Average True Range (ATR)
  • LXEO 0.48
  • VERI 0.18
  • MACD
  • LXEO 0.24
  • VERI 0.03
  • Stochastic Oscillator
  • LXEO 76.89
  • VERI 45.90

About LXEO Lexeo Therapeutics Inc.

Lexeo Therapeutics Inc is a a clinical-stage genetic medicines company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated. Its pipeline consists of candidates targeting patient populations that place significant burden on society and are most amenable to their genetic medicine approach. The Company is focused on preclinical and clinical stage gene therapies, and specifically on hereditary and acquired diseases of high unmet need which is their only business segment.

About VERI Veritone Inc.

Veritone Inc is a provider of artificial intelligence (AI) computing solutions and services. It generates revenue through the delivery of its Software Products and Services which consists of revenues generated from Commercial Enterprise and Government and Regulated Industries customers using the company's aiWARE platform and hiring solutions, any related support and maintenance services, and any related professional services associated with the deployment and/or implementation of such solutions, Managed Services which consist of revenues generated from Commercial Enterprise customers using company's content licensing services, advertising agency, influencer management and related services. It has a presence in the United States, the United Kingdom, France, Australia, Israel and India.

Share on Social Networks: